Works matching DE "HYDROXYCHLOROQUINE"
Results: 1474
Case report: hydroxychloroquine infiltrative cardiomyopathy.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Komedoni i atrofični ožiljci kao rijetka prezentacija kroničnog kutanog eritemskog lupusa – prikaz slučaja.
- Published in:
- Medicina Fluminensis, 2025, v. 61, n. 1, p. 92, doi. 10.21860/medflum2025_323591
- By:
- Publication type:
- Article
Evaluation and comparison of vitamin A supplementation with standard therapies in the treatment of patients with COVID-19.
- Published in:
- Eastern Mediterranean Health Journal, 2022, v. 28, n. 9, p. 673, doi. 10.26719/emhj.22.064
- By:
- Publication type:
- Article
Infodemic, self-medication and stockpiling: a worrying combination.
- Published in:
- Eastern Mediterranean Health Journal, 2021, v. 27, n. 5, p. 438, doi. 10.26719/emhj.21.010
- By:
- Publication type:
- Article
Determine and remove the drug trigger, usually antibiotics, that causes acute generalised exanthematous pustulosis.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 4, p. 141, doi. 10.1007/s40267-024-01064-x
- By:
- Publication type:
- Article
Hydroxychloroquine Retinal Toxicity: a Teaching Case Report.
- Published in:
- Optometric Education, 2021, v. 46, n. 3, p. 18
- By:
- Publication type:
- Article
Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 2, p. 297, doi. 10.1007/s10557-022-07387-z
- By:
- Publication type:
- Article
The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 4, p. 621, doi. 10.1007/s10557-022-07408-x
- By:
- Publication type:
- Article
Hydroxychloroquine suppresses anti-GBM nephritis via inhibition of JNK/p38 MAPK signaling.
- Published in:
- Clinical & Experimental Nephrology, 2023, v. 27, n. 2, p. 110, doi. 10.1007/s10157-022-02285-y
- By:
- Publication type:
- Article
Zebra bodies without Fabry disease or hydroxychloroquine.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 1, p. 94, doi. 10.1007/s10157-020-01965-x
- By:
- Publication type:
- Article
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 1, p. 87, doi. 10.1007/s10067-023-06714-5
- By:
- Publication type:
- Article
Low estimated glomerular filtration rate is an independent risk factor for higher hydroxychloroquine concentration.
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 7, p. 1943, doi. 10.1007/s10067-023-06576-x
- By:
- Publication type:
- Article
Hydroxychloroquine: is there a role in long COVID?
- Published in:
- Clinical Rheumatology, 2023, v. 42, n. 3, p. 977, doi. 10.1007/s10067-023-06514-x
- By:
- Publication type:
- Article
Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 11, p. 3345, doi. 10.1007/s10067-022-06282-0
- By:
- Publication type:
- Article
Pulmonary amyloidosis and cystic lung disease in primary Sjögren's syndrome: a case report and literature review.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3345, doi. 10.1007/s10067-021-05596-9
- By:
- Publication type:
- Article
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 7, p. 2745, doi. 10.1007/s10067-021-05600-2
- By:
- Publication type:
- Article
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 8, p. 2461, doi. 10.1007/s10067-020-05202-4
- By:
- Publication type:
- Article
Determination of Hydroxychloroquine by Cathodic Electrochemiluminescence.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 55, n. 10, p. 1115, doi. 10.1007/s11094-021-02545-3
- By:
- Publication type:
- Article
Hydroxychloroquine-induced hyperpigmentation in a patient with anti-synthetase syndrome.
- Published in:
- Portuguese Journal of Dermatology & Venereology, 2024, v. 82, n. 4, p. 253, doi. 10.24875/PJDV.24000054
- By:
- Publication type:
- Article
Kinetic Studies for the Release of Hydroxychloroquine Sulphate Drug (HCQ) In-vitro in Simulated Gastric and Intestinal Medium from Sodium Alginate and Lignosulphonic Acid Blends.
- Published in:
- Trends in Sciences, 2023, v. 20, n. 5, p. 1, doi. 10.48048/tis.2023.5318
- By:
- Publication type:
- Article
COVID-19 in Kidney Transplant Recipients, Single Center Study From Turkey.
- Published in:
- Haydarpasa Numune Medical Journal, 2022, v. 62, n. 4, p. 470, doi. 10.14744/hnhj.2021.73626
- By:
- Publication type:
- Article
Chronic Q fever presenting as bilateral extensor tenosynovitis: a case report and review of the literature.
- Published in:
- Journal of Bone & Joint Infection (JBJI), 2023, v. 8, n. 1, p. 39, doi. 10.5194/jbji-8-39-2023
- By:
- Publication type:
- Article
A Hydroxychloroquine-Related Acute Severe Liver Disease.
- Published in:
- Türkiye Klinikleri Journal of Case Reports, 2022, v. 30, n. 2, p. 118, doi. 10.5336/caserep.2021-87036
- By:
- Publication type:
- Article
Should azithromycin be used to treat COVID-19? A rapid review.
- Published in:
- BJGP Open, 2020, v. 4, n. 2, p. 1, doi. 10.3399/bjgpopen20X101094
- By:
- Publication type:
- Article
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review.
- Published in:
- BJGP Open, 2020, v. 4, n. 2, p. 1, doi. 10.3399/bjgpopen20X101069
- By:
- Publication type:
- Article
Focal Segmental Glomerulosclerosis in Primary Sjogren Syndrome.
- Published in:
- Asian Journal of Pediatric Nephrology, 2023, v. 6, n. 1, p. 24, doi. 10.4103/ajpn.ajpn_19_22
- By:
- Publication type:
- Article
COVID-19 Treatments ..... a spark of hope.
- Published in:
- Journal of Wasit for Science & Medicine, 2020, p. 69
- By:
- Publication type:
- Article
Repurposing of Hydroxychloroquine (HCQ} and Azithromycin in Prophylaxis and Treatment of COVID-19 disease.
- Published in:
- Indian Journal of Basic & Applied Medical Research, 2020, v. 9, n. 3, p. 31, doi. 10.36848/IJBAMR/2020/12215.51515
- By:
- Publication type:
- Article
Reacciones adversas a medicamentos utilizados para la COVID-19 en cinco países de América Latina.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2022, v. 46, p. 1, doi. 10.26633/RPSP.2022.178
- By:
- Publication type:
- Article
Eventos adversos no sistema nervoso central potencialmente relacionados aos medicamentos utilizados na COVID-19: revisão de escopo.
- Published in:
- Pan American Journal of Public Health / Revista Panamericana de Salud Pública, 2022, v. 46, p. 1, doi. 10.26633/RPSP.2022.166
- By:
- Publication type:
- Article
Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement.
- Published in:
- Journal of Health Politics, Policy & Law, 2022, v. 47, n. 4, p. 429, doi. 10.1215/03616878-9716698
- By:
- Publication type:
- Article
The Paradoxes of the Pandemic and World Inequalities.
- Published in:
- Social Sciences (2076-0760), 2021, v. 10, n. 9, p. 332, doi. 10.3390/socsci10090332
- By:
- Publication type:
- Article
Bir Multisentrik Retikülohistiyositoz Olgusu.
- Published in:
- Turkiye Klinikleri Journal of Dermatology, 2021, v. 31, n. 1, p. 45, doi. 10.5336/dermato.2019-66473
- By:
- Publication type:
- Article
沙参麦冬汤联合硫酸羟氯喹治疗气阴两虚型原发性干燥综合征的 疗效及对 Th17/Treg 免疫失衡的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 4, p. 676, doi. 10.13241/j.cnki.pmb.2023.04.015
- By:
- Publication type:
- Article
Corrigendum to "Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births".
- Published in:
- 2022
- By:
- Publication type:
- corrected article
A critical analysis and review of Lancet COVID-19 hydroxychloroquine study.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2020.1809236
- By:
- Publication type:
- Article
Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.
- Published in:
- Journal of Market Access & Health Policy, 2020, v. 8, n. 1, p. 1, doi. 10.1080/20016689.2020.1758390
- By:
- Publication type:
- Article
Hydroxychloroquine for COVID-19: A Single Center, Retrospective Cohort Study.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2023, v. 19, n. 2, p. 8, doi. 10.47836/mjmhs19.2.3
- By:
- Publication type:
- Article
Comparative Retrospective Cohort Study On The Safety And Effectiveness Of Hydroxychloroquine In The Management Of COVID-19: A Malaysia Single Centre Experience.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
HPLC Method Development And Validation For The Determination Of Hydroxychloroquine In Human Whole Blood.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2022, v. 18, p. 50
- By:
- Publication type:
- Article
Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9171715
- By:
- Publication type:
- Article
Factors Affecting the Incidence, Progression, and Severity of COVID-19 in Type 1 Diabetes Mellitus.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/1676914
- By:
- Publication type:
- Article
Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6614000
- By:
- Publication type:
- Article
Hydroxychloroquine and the associated risk of arrhythmias.
- Published in:
- Global Cardiology Science & Practice, 2024, v. 2024, n. 2, p. 96, doi. 10.21542/gcsp.2024.17
- By:
- Publication type:
- Article
Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.
- Published in:
- Global Cardiology Science & Practice, 2021, v. 2021, n. 2, p. 1, doi. 10.21542/gcsp.2021.11
- By:
- Publication type:
- Article
Mepolizumab Therapy for Recalcitrant Eosinophilic Annular Erythema in an Adult: A Case Report and Review of Treatment Options.
- Published in:
- Dermatology & Therapy, 2020, v. 10, n. 4, p. 893, doi. 10.1007/s13555-020-00412-9
- By:
- Publication type:
- Article
Impact of Hydroxychloroquine, on QTc Interval, in Patients with Rheumatologic Diseases.
- Published in:
- Annals of King Edward Medical University, 2023, v. 29, n. 4, p. 315, doi. 10.21649/akemu.v23i4.4725
- By:
- Publication type:
- Article
Author Correction: An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58391-2
- By:
- Publication type:
- Article